BMB Gets Patent for Protein Purification System
View the abstract in our Arkansas patent database here.
The NWA Business Journal this week spoke with BMB founder Ellen Brune about the patent, licensed to the UA Board of Trustees and the University of Pittsburgh.
“It’s a great milestone to hit,” Brune said of the validation from the United States Patent and Trademark Office. “If a patent is not awarded, you really don’t have much.”
Known as Lotus, the technology uses production-ready E. coli cell strains with minimal amounts of contaminant proteins, thus making it easier to find the target protein and separate it during the process of making a pharmaceutical. Boston Mountain’s market is protein pharmaceutical manufacturers, the makers of IV and injection drugs used in the treatment of serious ailments such as diabetes, arthritis and cancer.
Good stuff. Keep up the good work, yall.